6ModricS,WebbAI.Derendorf H.Pharmacokinetics and pharmacodynamics of ticlmicosin in sheep and cattle.Journd of Veterinary Pharmaco & Therapeutics.1998,21(6):444-452
7Frank GH,Robert BE.Effects of tilmicosin treament on Pasteurella haemolytica organisms in nasal secretion specimens of calves with respiratory tract disease.American Journal of Veterinary Research.2000,61 (5):525-529
8Scorneaux B,Thomas S R.Intracellular accumulation,subcellular distribution,and efflux of tilmicosin in borine mammary blacd,and lung cells.Journal of Dairy Science,1999,82(6):1201-1212
9Sarja M,Webb A I.Maureen D.Effect of resppiratoyy tract disease on pharmacokinetics of tilmicosin in rat.Laboratory Animal Science.1999,49(3):248-253
10Scorneaux B,Shryock T R.Int racellular accumulation,subcellular distribution and efflux of tilmicasin in swine phagocytes.Journal of Veterinary P harmacogy & Therpeutics.1998,21 (4):276-284.
二级参考文献55
1阎继业 邓旭明 刘公玺.畜禽药物手册[M].北京:金盾出版社,2003..
2Zielinski G C, Piscitelli H G, Perez M H, et al. Efficacy of differentdosage levels and routes of inoculation of tilmicosin in a natural outbreakof infectious bovine keratoconjunctivitis[R]. Proceedings of the Thirty-Second Annual Conference American Association of Bovine Practitioners,1999.261.
3Gokce G, Sahin M, Genc O, et al. Comparative studies on the efficacyof tilmicosin and danofloxacin in treating calf pneumonia [J]. KafkasUniversitesi Veteriner Fakultesi Dergisi, 1997, 3(2):151-155.
4Kempf I, Reeve J L, Gesbert F, et al. Efficacy of tilmicosin in the controlof experimental Mycoplasma gallisepticum infection in chickens [J].Avian Diseases, 1997, 41(4):802-807.
5Nickerson S C, Owens W E, Fox L K, et al. Comparison of tilmicosinand cephapirin as therapeutics for Staphylococus aureus mastitis atdry-off [J]. Journal of Dairy Science, 1999, 82(4):696-703.
6Croft A, Duffield T, Menzies P, et al. The effect of tilmicosin administeredto ewes prior to lambing on incidence of clinical mastitis and subsequentlamb performance[J]. Canadian Veterinary Journal, 2000, 41(4):306-311.
7Ose E E. In vitro antibacterial properties EL-870, a new semi-synthetic macrolide antibiotic [J]. Journal of Antibiotics, 1987, 40: 190-194.
8Blackall P J, Asakawa T, Graydon R J, et al. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella rmultocida and Actinobacillus pleuropneumoniae from pigs[J]. Australian Veterinary Journal,1995, 72 (1): 35-36.
9Stephens C P, Blackall P J, Wade L K, et al. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Pasteurella haemolytica from cattle[J]. Australian Veterinary Journal,1993, 70(10): 391-392.
10Avling R D, Baker S E, NicholasR A J,et al. Comparison of in vitro activity of danofloxacin, florfenicol, oxytetracycline, spectinomvcin and tilmicosin against Mycoplasma mycoides subspecies mvcoides small colony type [J].Veterinary Record, 2000, 146 (9):243-246.
